LE WE PMID CA
Systemic lupus erythematosus2668Systemischer Lupus Erythematosus

Aicardi Goutieres syndrome

AIM2

Antiinflammatory compounds

Antiphospholipid syndrome

APRIL

Arterial hypertension (BASKET)

Arthritis (rheumatoid)

Autoantibodies Anti alpha actinin

Autoantibodies Anti beta 2 glycoprotein I

Autoantibodies Anti dsDNA Anti ssDNA

Autoimmunity

B Cell (B1)

B Zelle L2pB1

BAFF

Belimumab ttBLyS

BLYS

CD180 RP105

Cyclophosphamide

Dendritic cell (Immunology)

Dendritic cell (Plasmacytoid)

DNA (Methylation)

Efferocytosis

Estrogen

Fatty acids (Omega3)

Genetics (GWAS Genome wide association study)

Heart (Arrhythmia)

Histone deacetylase

IFI16

Ifi200 protein family

Ifi202a

Ifi202b

Ifi203

Ifi204

Ifi205

IFIX

IgA nephropathy

Immunopsychiatry

Interferon alpha and preliminary (BASKET)

Interleukin17

Interleukin21

Interleukin6

Jaccoud s arthropathy

Kidney (C1q nephropathy)

Leukocyte (Extravasation and Trafficking)

Libman Sacks endocarditis

Macrophage activation syndrome

Mitochondria (Hyperpolarization)

Mitral valve (Regurgitation)

MNDA

MRL LPR mouse

MTOR

Neutropenia (autoimmune)

Osteoporosis

Pancreatitis (BASKET)

PD L2

Pregnancy (Diseases)

Prgnancy (High risk pregnancy)

PTPN22

Receptor (Antibody Fc)

Regulatory T cell

Reversible posterior cerebral edema

Reversible posterior leukoencephalopathy syndrome

Rituximab ttCD20

RNA (MicroRNA)

Rowell s syndrome

RP105

Statistics and trial design

Systemic lupus erythematosus

T cell (CD8pos)

T cell (double negative)

T Cell (Signal transduction)

Tacrolimus FK506

TLR7

TLR9

TNFAIP3 A20

Tolerance (Immunology)

Toll like receptor

TREX1

TWEAK Fn14

1993  
1
Psychiatric symptoms in systemic lupus erythematosus: an update.
[8475237] Psychosom Med 55(2): 219-28 (1993)
1972  
2
The study of the psychiatric symptoms of systemic lupus erythematosus.. A critical review.
[4556060] Psychosom Med 34(3): 199-206 (1972)
2006  
3
Systemic lupus erythematosus.
[16613963] BMJ 332(7546): 890-4 (2006)
1995  
4
ABC of rheumatology. Systemic lupus erythematosus and lupus-like syndromes.
[7767201] BMJ 310(6989): 1257-61 (1995)
1993  
5
Diagnosis and treatment of systemic lupus erythematosus.
[8401055] BMJ 307(6905): 663-6 (1993)
1979  
6
Systemic lupus erythematosus: treatment and prognosis.
[391327] Br Med J 2(6197): 1019-22 (1979)
1975  
7
Editorial: Cerebral lupus.
[124612] Br Med J 1(5957): 537-8 (1975)
1973  
8
Mortality in systemic lupus erythematosus: a 10-year review.
[4758576] Br Med J 4(5895): 772-4 (1973)
2009  
9
Usefulness of ISN/RPS classification of lupus nephritis.
[19194566] J Korean Med Sci 24 Suppl(-): S7-10 (2009)
2003  
10
The pathogenesis of systemic lupus erythematosus.
[14768716] Neth J Med 61(11): 343-6 (2003)
2003  
11
Lupus nephritis: consequence of disturbed removal of apoptotic cells?
[14628957] Neth J Med 61(8): 233-8 (2003)
2009  
12
Lupus update: perspective and clinical pearls.
[19188480] Cleve Clin J Med 76(2): 137-42 (2009)
2008  
13
Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.
[19936286] Curr Cardiol Rev 4(2): 116-22 (2008)
2006  
14
Mechanisms of dyslipoproteinemias in systemic lupus erythematosus.
[17162363] Clin Dev Immunol 13(2-4): 203-8 (2006)
2006  
15
The epigenetic face of systemic lupus erythematosus.
[16751355] J Immunol 176(12): 7143-7 (2006)
2009  
16
The role of extracellular DNA in autoimmunity in SLE.
[19703007] Scand J Immunol 70(3): 175-83 (2009)
2006  
17
Autoantibody determination in the diagnosis of systemic lupus erythematosus.
[16918691] Scand J Immunol 64(3): 227-35 (2006)
2006  
18
Regulatory T cells and systemic lupus erythematosus.
[16918689] Scand J Immunol 64(3): 211-8 (2006)
2004  
19
Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
[15238073] Scand J Immunol 60(1-2): 52-63 (2004)
2005  
20
New therapies for systemic lupus erythematosus.
[15807843] Clin Exp Immunol 140(2): 205-12 (2005)
1981  
21
Current perspectives on serological reactions in SLE patients.
[7021022] Clin Exp Immunol 44(1): 1-10 (1981)
2004  
22
Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus.
[15131354] J Appl Genet 45(2): 237-48 (2004)
1994  
23
Nephritogenic antibodies in MRL/lpr lupus mice: molecular characteristics in pathological and genetic aspects.
[7809912] Tohoku J Exp Med 173(1): 65-74 (1994)
1994  
24
Nephritogenic antibodies in lupus nephritis.
[7809910] Tohoku J Exp Med 173(1): 31-41 (1994)
2008  
25
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
[17504841] Ann Rheum Dis 67(2): 195-205 (2008)
2006  
26
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.
[16079164] Ann Rheum Dis 65(2): 144-8 (2006)
2005  
27
Autoantibodies to opsonins of apoptotic cells in systemic lupus erythematosus.
[16284341] Ann Rheum Dis 64(12): 1669-70 (2005)
2005  
28
How to monitor SLE in routine clinical practice.
[15769911] Ann Rheum Dis 64(4): 524-7 (2005)
2003  
29
Treatment of severe proliferative lupus nephritis: the current state.
[12922948] Ann Rheum Dis 62(9): 799-804 (2003)
2002  
30
Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis).
[12006332] Ann Rheum Dis 61(6): 547-50 (2002)
1995  
31
Controversies in lupus: nervous system involvement.
[7748011] Ann Rheum Dis 54(3): 159-67 (1995)
1992  
32
Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?
[1575582] Ann Rheum Dis 51(3): 358-61 (1992)
2009  
33
How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?
[19960581] Arthritis Res Ther 11(5): 129 (2009)
2009  
34
Developments in the clinical understanding of lupus.
[19849817] Arthritis Res Ther 11(5): 245 (2009)
2009  
35
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.
[19591653] Arthritis Res Ther 11(3): 234 (2009)
2008  
36
Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.
[19090960] Arthritis Res Ther 10(6): 229 (2008)
2008  
37
Regulatory T cells in systemic lupus erythematosus: past, present and future.
[19040771] Arthritis Res Ther 10(6): 227 (2008)
2008  
38
Developments in the scientific understanding of lupus.
[18947369] Arthritis Res Ther 10(5): 218 (2008)
2003  
39
Microarray analysis of gene expression in lupus.
[14680503] Arthritis Res Ther 5(6): 279-87 (2003)
2003  
40
Systemic lupus erythematosus and the type I interferon system.
[12718746] Arthritis Res Ther 5(2): 68-75 (2003)
1996  
41
Cellular interactions in the lpr and gld models of systemic autoimmunity.
[8934931] Adv Dent Res 10(1): 76-80 (1996)
2008  
42
Lupus nephritis: the central role of nucleosomes revealed.
[18187568] Am J Pathol 172(2): 275-83 (2008)
1995  
43
Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis.
[7762914] Ann Intern Med 123(1): 42-53 (1995)
1995  
44
Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease.
[7755231] Ann Intern Med 122(12): 940-50 (1995)
2006  
45
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis.
[17163990] Arthritis Res Ther 8(6): R182 (2006)
2008  
46
Cognitive dysfunction in systemic lupus erythematosus: past, present, and future.
[18975345] Arthritis Rheum 58(11): 3286-98 (2008)
2008  
47
Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus.
[18576314] Arthritis Rheum 58(7): 1892-9 (2008)
2008  
48
Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus.
[18311758] Arthritis Rheum 59(3): 332-7 (2008)
2007  
49
Measurement of fatigue in systemic lupus erythematosus: a systematic review.
[18050225] Arthritis Rheum 57(8): 1348-57 (2007)
2007  
50
Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms.
[17599763] Arthritis Rheum 56(7): 2344-51 (2007)
2005  
51
Pituitary hormones and systemic lupus erythematosus.
[16320320] Arthritis Rheum 52(12): 3701-12 (2005)
2004  
52
Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.
[15248202] Arthritis Rheum 50(7): 2048-65 (2004)
2004  
53
Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability.
[15188346] Arthritis Rheum 50(6): 1709-20 (2004)
2002  
54
Choosing treatment for proliferative lupus nephritis.
[12209498] Arthritis Rheum 46(8): 1981-3 (2002)
2002  
55
What do we know about lupus membranous nephropathy? An analytic review.
[12209494] Arthritis Rheum 47(4): 450-5 (2002)
2002  
56
Abnormal T cell signal transduction in systemic lupus erythematosus.
[12115215] Arthritis Rheum 46(5): 1139-54 (2002)
1999  
57
The key role of nucleosomes in lupus.
[10323438] Arthritis Rheum 42(5): 833-43 (1999)
1999  
58
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.
[10211873] Arthritis Rheum 42(4): 599-608 (1999)
1996  
59
Michael Mason Prize Essay 1995. Complement, immune complexes and systemic lupus erythematosus.
[8624623] Br J Rheumatol 35(1): 5-23 (1996)
2008  
60
Pulmonary and thrombotic manifestations of systemic lupus erythematosus.
[18187752] Chest 133(1): 271-80 (2008)
2000  
61
Alveolar hemorrhage in systemic lupus erythematosus: presentation and management.
[11035681] Chest 118(4): 1083-90 (2000)
2008  
62
What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?
[18287258] Clin J Am Soc Nephrol 3(3): 895-8 (2008)
2007  
63
Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
[17702723] Clin J Am Soc Nephrol 2(5): 968-75 (2007)
2007  
64
Role of mycophenolate mofetil in the treatment of lupus nephritis.
[17702717] Clin J Am Soc Nephrol 2(5): 879-82 (2007)
2006  
65
New therapies for lupus nephritis.
[17699298] Clin J Am Soc Nephrol 1(4): 863-8 (2006)
2004  
66
Management of lupus nephritis: an update.
[15466274] J Am Soc Nephrol 15(10): 2694-704 (2004)
1999  
67
2003  
68
Pathogenesis of systemic lupus erythematosus.
[12835292] J Clin Pathol 56(7): 481-90 (2003)
2007  
69
Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
[17405792] Nephrol Dial Transplant 22(7): 1933-42 (2007)
2006  
70
1993  
71
Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).
[8234102] Postgrad Med J 69(814): 602-8 (1993)
2007  
72
Ocular manifestations of systemic lupus erythematosus.
[17681981] Rheumatology (Oxford) 46(12): 1757-62 (2007)
2005  
73
Complement and its breakdown products in SLE.
[15972354] Rheumatology (Oxford) 44(10): 1227-32 (2005)
2005  
74
Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus.
[15914499] Rheumatology (Oxford) 44(9): 1086-9 (2005)
2002  
75
Long-term complications of systemic lupus erythematosus.
[12364626] Rheumatology (Oxford) 41(10): 1095-100 (2002)
2002  
76
The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.
[12048287] Rheumatology (Oxford) 41(6): 619-30 (2002)
2002  
77
The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation.
[12048286] Rheumatology (Oxford) 41(6): 605-18 (2002)
2000  
78
Links between complement abnormalities and systemic lupus erythematosus.
[10725062] Rheumatology (Oxford) 39(2): 133-41 (2000)
2000  
79
Systemic lupus erythematosus-messages from experimental models.
[10662869] Rheumatology (Oxford) 39(1): 18-27 (2000)
1999  
80
A review of gastrointestinal manifestations of systemic lupus erythematosus.
[10534541] Rheumatology (Oxford) 38(10): 917-32 (1999)
1985  
81
Heart disease in systemic lupus erythematosus: diagnosis and management.
[15227037] Tex Heart Inst J 12(1): 9-21 (1985)
2000  
82
Pleuropulmonary manifestations of systemic lupus erythematosus.
[10639536] Thorax 55(2): 159-66 (2000)
1975  
83
Editorial: Pathogenesis of systemic lupus erythematosus.
[1078744] West J Med 122(2): 157-8 (1975)
1975  
84
Recent advances in the immunopathogenesis of systemic lupus erythematosus.
[46657] West J Med 122(2): 130-44 (1975)
2005  
85
Acute pancreatitis as an initial symptom of systemic lupus erythematosus: a case report and review of the literature.
[16094728] World J Gastroenterol 11(30): 4766-8 (2005)
1997  
86
1994  
87
Lupus nephritis: lessons from the path lab.
[8196299] Kidney Int 45(3): 928-38 (1994)
1992  
88
Induction and progression of experimental lupus nephritis: exploration of a pathogenetic pathway.
[1593861] Kidney Int 41(1): 5-13 (1992)
1986  
89
The treatment of lupus nephritis.
[3537464] Kidney Int 30(5): 769-87 (1986)
2004  
90
Imaging findings in systemic lupus erythematosus.
[15256629] Radiographics 24(4): 1069-86 (2004)
2008  
91
The clinical importance of lymphadenopathy in systemic lupus erythematosus.
[19107085] Acta Reumatol Port 33(4): 402-6 (2008)
2008  
92
Novel therapies in lupus - focus on nephritis.
[18604181] Acta Reumatol Port 33(2): 157-69 (2008)
2010  
93
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.
[19892750] Ann Rheum Dis 69(7): 1269-74 (2010)
2011  
94
Disturbances of apoptotic cell clearance in systemic lupus erythematosus.
[21371352] Arthritis Res Ther 13(1): 202 (2011)
2011  
95
Chromatin as a target antigen in human and murine lupus nephritis.
[21542875] Arthritis Res Ther 13(2): 214 (2011)
2003  
96
B cell abnormalities in systemic lupus erythematosus.
[15180894] Arthritis Res Ther 5 Suppl 4(-): S22-7 (2003)
2010  
97
A new tool for detection of type I interferon activation in systemic lupus erythematosus.
[20815919] Arthritis Res Ther 12(4): 138 (2010)
2010  
98
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
[20609263] Arthritis Res Ther 12(3): 210 (2010)
2010  
99
The role of dendritic cells in the pathogenesis of systemic lupus erythematosus.
[20423534] Arthritis Res Ther 12(2): 207 (2010)
2010  
100
Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes).
[20441604] Arthritis Res Ther 12(2): 111 (2010)
2010  
101
Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.
[20122288] Arthritis Res Ther 12(1): 101 (2010)
2009  
102
The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritis.
[20017900] Arthritis Res Ther 11(6): 137 (2009)
2009  
103
Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis.
[19939293] Arthritis Res Ther 11(6): 255 (2009)
2009  
104
TWEAK: a novel biomarker for lupus nephritis?
[19951398] Arthritis Res Ther 11(6): 133 (2009)
2004  
105
Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis.
[15334435] Arthritis Rheum 51(4): 609-15 (2004)
2004  
106
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
[15529383] Arthritis Rheum 50(11): 3418-26 (2004)
2004  
107
Cyclophosphamide for severe lupus nephritis: where are we now?
[15593210] Arthritis Rheum 50(12): 3748-50 (2004)
2003  
108
Sex hormones and systemic lupus erythematosus: review and meta-analysis.
[12905462] Arthritis Rheum 48(8): 2100-10 (2003)
2003  
109
Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms?
[12571837] Arthritis Rheum 48(2): 300-12 (2003)
2009  
110
Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need?
[19333929] Arthritis Rheum 60(4): 912-5 (2009)
2009  
111
Systemic lupus erythematosus: a matter of life and death.
[19479835] Arthritis Rheum 60(6): 1567-70 (2009)
2009  
112
Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
[19877067] Arthritis Rheum 60(11): 3388-99 (2009)
2009  
113
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.
[19714582] Arthritis Rheum 60(9): 2558-64 (2009)
2007  
114
Systemic lupus erythematosus.
[17974690] BMJ 335(7626): 933-6 (2007)
2006  
115
Targeting of B cells in SLE: rationale and therapeutic opportunities.
[17121490] Bull NYU Hosp Jt Dis 64(1-2): 51-6 (2006)
2010  
116
Trials and tribulations in systemic lupus erythematosus.
[20969548] Bull NYU Hosp Jt Dis 68(3): 175-8 (2010)
2007  
117
B cell biology and dysfunction in SLE.
[17922667] Bull NYU Hosp Jt Dis 65(3): 182-6 (2007)
2007  
118
Biomarker discovery in human SLE nephritis.
[17922668] Bull NYU Hosp Jt Dis 65(3): 187-93 (2007)
2007  
119
Neuropsychiatric lupus: clinical and imaging aspects.
[17922669] Bull NYU Hosp Jt Dis 65(3): 194-9 (2007)
2007  
120
Cutaneous lupus: insights into pathogenesis and disease classification.
[17922670] Bull NYU Hosp Jt Dis 65(3): 200-4 (2007)
2008  
121
Lupus nephritis: histology, diagnosis, and treatment.
[18937630] Bull NYU Hosp Jt Dis 66(3): 188-94 (2008)
2008  
122
Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench.
[18937629] Bull NYU Hosp Jt Dis 66(3): 184-7 (2008)
2008  
123
The genetic contribution to systemic lupus erythematosus.
[18937628] Bull NYU Hosp Jt Dis 66(3): 176-83 (2008)
2010  
124
Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment.
[20572299] World J Gastroenterol 16(24): 2971-7 (2010)
2010  
125
Updates on the treatment of lupus nephritis.
[21051743] J Am Soc Nephrol 21(12): 2028-35 (2010)
2004  
126
Reclassification of lupus glomerulonephritis: back to the future.
[14747399] J Am Soc Nephrol 15(2): 501-3 (2004)
2009  
127
Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.
[19329762] J Am Soc Nephrol 20(4): 696-704 (2009)
2004  
128
Distinguishing C1q nephropathy from lupus nephritis.
[15004260] Nephrol Dial Transplant 19(6): 1420-6 (2004)
2004  
129
Deranged removal of apoptotic cells: its role in the genesis of lupus.
[14736945] Nephrol Dial Transplant 19(2): 282-5 (2004)
2009  
130
How did cyclophosphamide become the drug of choice for lupus nephritis?
[19056783] Nephrol Dial Transplant 24(2): 381-4 (2009)
2006  
131
Looking backward: a review of the treatment of systemic lupus erythematosus in end-stage renal disease after a quarter of century.
[16384832] Nephrol Dial Transplant 21(6): 1739 (2006)
2011  
132
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.
[21331367] J Biomed Biotechnol 2011(-): 207504 (2011)
2011  
133
Murine models of systemic lupus erythematosus.
[21403825] J Biomed Biotechnol 2011(-): 271694 (2011)
2010  
134
Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.
[20625508] J Biomed Biotechnol 2010(-): 686480 (2010)
2010  
135
Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.
[20652041] J Biomed Biotechnol 2010(-): 294582 (2010)
2010  
136
Interferon alpha in systemic lupus erythematosus.
[20652065] J Biomed Biotechnol 2010(-): 948364 (2010)
2010  
137
Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.
[20671931] J Biomed Biotechnol 2010(-): 457146 (2010)
2010  
138
Anti-TNF-alpha therapies in systemic lupus erythematosus.
[20625488] J Biomed Biotechnol 2010(-): 465898 (2010)
2010  
139
Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.
[20617145] J Biomed Biotechnol 2010(-): 268436 (2010)
2010  
140
Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.
[20467470] J Biomed Biotechnol 2010(-): 365083 (2010)
2010  
141
Cytokine networks in systemic lupus erythematosus.
[20414360] J Biomed Biotechnol 2010(-): 676284 (2010)
2010  
142
Biomarkers for lupus nephritis: a critical appraisal.
[20414362] J Biomed Biotechnol 2010(-): 638413 (2010)
2010  
143
IL-17 in systemic lupus erythematosus.
[20379379] J Biomed Biotechnol 2010(-): 943254 (2010)
2010  
144
Cytokines in systemic lupus erythematosus.
[21603232] J Biomed Biotechnol 2010(-): 735169 (2010)
2010  
145
Genetics of systemic lupus erythematosus: contributions of mouse models in the era of human genome-wide association studies.
[20670601] Discov Med 10(50): 71-8 (2010)
2011  
146
Treating lupus in the kidney: where are we now, and where are we going?
[22031671] Discov Med 12(65): 341-9 (2011)
2010  
147
Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?
[21122473] Discov Med 10(54): 416-24 (2010)
2010  
148
mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?
[20350481] Discov Med 9(46): 173-8 (2010)
2010  
149
Biologic therapy for systemic lupus erythematosus.
[20102681] Discov Med 9(44): 20-3 (2010)
2009  
150
The busy life of regulatory T cells in systemic lupus erythematosus.
[19772836] Discov Med 8(40): 13-7 (2009)
2010  
151
IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.
[20808864] PLoS One 5(8): e12280 (2010)
2010  
152
The role of B cells in lupus pathogenesis.
[19850148] Int J Biochem Cell Biol 42(4): 543-50 (2010)
2005  
153
Cellular and molecular mechanisms of regulation of autoantibody production in lupus.
[16126985] Ann N Y Acad Sci 1051(-): 433-41 (2005)
2008  
154
Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease.
[18658205] Rheumatology (Oxford) 47(10): 1498-502 (2008)
2004  
155
Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management.
[12867578] Rheumatology (Oxford) 43(1): 7-12 (2004)
2003  
156
Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus.
[12595613] Rheumatology (Oxford) 42(2): 214-22 (2003)
2009  
157
Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!
[19155279] Rheumatology (Oxford) 48(4): 332-41 (2009)
2008  
158
Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma.
[18084001] Rheumatology (Oxford) 47(3): 256-62 (2008)
2008  
159
Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
[18577549] Rheumatology (Oxford) 47(9): 1367-72 (2008)
2008  
160
2006  
161
Moderate and severe neutropenia in patients with systemic lupus erythematosus.
[16484291] Rheumatology (Oxford) 45(8): 994-8 (2006)
2009  
162
Osteoporosis in patients with systemic lupus erythematosus.
[19891237] Isr Med Assoc J 11(8): 486-91 (2009)
2008  
163
A novel synthetic peptide for the specific treatment of lupus: clinical effects and mechanism of action.
[18300570] Isr Med Assoc J 10(1): 40-2 (2008)
2008  
164
The story of the 16/6 idiotype and systemic lupus erythematosus.
[18300569] Isr Med Assoc J 10(1): 37-9 (2008)
2008  
165
Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis.
[18451582] Intern Med 47(9): 867-75 (2008)
2004  
166
Conference report--lupus nephritis: diagnosis, therapy, and outcomes.
[15520647] MedGenMed 6(3): 23 (2004)
2010  
167
2010  
168
Review article: systemic lupus erythematosus: a review for anesthesiologists.
[20601448] Anesth Analg 111(3): 665-76 (2010)
2003  
169
Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity.
[12605690] Clin Exp Immunol 131(3): 396-7 (2003)
2009  
170
Interleukin-17 and systemic lupus erythematosus: current concepts.
[19604260] Clin Exp Immunol 157(2): 209-15 (2009)
2012  
171
Imaging assessment of cardiovascular disease in systemic lupus erythematosus.
[22110536] Clin Dev Immunol 2012(-): 694143 (2012)
2012  
172
RP105-negative B cells in systemic lupus erythematosus.
[21941580] Clin Dev Immunol 2012(-): 259186 (2012)
2010  
173
Targeting Toll-like receptors for treatment of SLE.
[20886024] Mediators Inflamm 2010(-): - (2010)
2004  
174
Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus.
[14994382] J Rheumatol 31(3): 419-21 (2004)
2004  
175
The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease?
[15517616] J Rheumatol 31(11): 2093-8 (2004)
2007  
176
Renal biopsy at the onset of clinical lupus nephritis: can it yield useful information?
[17304650] J Rheumatol 34(2): 256-8 (2007)
2006  
177
Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure.
[16881102] J Rheumatol 33(8): 1464-6 (2006)
2009  
178
Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.
[19808788] Hum Mol Genet 18(R2): R130-6 (2009)
2009  
179
Pancreatitis and systemic lupus erythematosus.
[19785498] Rev Esp Enferm Dig 101(8): 571-9 (2009)
2011  
180
HDAC inhibition in lupus models.
[21327298] Mol Med 17(5-6): 417-25 (2011)
2009  
181
Biomarkers for lupus nephritis: the quest continues.
[19729426] Clin J Am Soc Nephrol 4(11): 1858-65 (2009)
2010  
182
The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.
[20360925] Clinics (Sao Paulo) 65(3): 327-33 (2010)
2008  
183
Vasculopathy and vasculitis in systemic lupus erythematosus.
[18405174] Pol Arch Med Wewn 118(1-2): 57-63 (2008)
2010  
184
Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.
[20347645] Semin Nephrol 30(2): 164-76 (2010)
2007  
185
Neuroimmunopathology in a murine model of neuropsychiatric lupus.
[17223198] Brain Res Rev 54(1): 67-79 (2007)
2007  
186
Nitric oxide, mitochondrial hyperpolarization, and T cell activation.
[17462531] Free Radic Biol Med 42(11): 1625-31 (2007)
2010  
187
Advances in drug therapy for systemic lupus erythematosus.
[21114845] BMC Med 8(-): 77 (2010)
2010  
188
Mouse models of systemic lupus erythematosus reveal a complex pathogenesis.
[20448279] Vet Pathol 47(4): 664-76 (2010)
2005  
189
Demographics and presenting clinical features of childhood systemic lupus erythematosus.
[16100891] S Afr Med J 95(6): 424-7 (2005)
2009  
190
Lupus erythematosus masquerading as erythema multiforme: does Rowell syndrome really exist?
[19336022] Dermatol Online J 15(2): 5 (2009)
2007  
191
The Hopkins Lupus Pregnancy Center: ten key issues in management.
[17499704] Rheum Dis Clin North Am 33(2): 227-35, v (2007)
2007  
192
2007  
193
Lupus erythematosus gyratus repens.
[17324834] Eur J Dermatol 17(1): 79-82 (2007)
2010  
194
Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.
[20331896] J Cardiothorac Surg 5(-): 13 (2010)
2011  
195
Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review.
[21350606] Cardiol Res Pract 2011(-): 578390 (2011)
2009  
196
Pathogenesis of kidney disease in systemic lupus erythematosus.
[19584729] Curr Opin Rheumatol 21(5): 489-94 (2009)
2009  
197
2009  
198
Malignancy in systemic lupus erythematosus: what have we learned?
[19591783] Best Pract Res Clin Rheumatol 23(4): 539-47 (2009)
2011  
199
Current views on etiopathogenesis of systemic lupus erythematosus.
[22100802] Postepy Hig Med Dosw (Online) 65(0): 683-703 (2011)
2010  
200
Arrhythmias in systemic lupus erythematosus.
[21125143] Rev Bras Reumatol 50(1): 81-9 (2010)
2007  
201
Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches.
[17437489] Exp Dermatol 16(5): 454-63 (2007)
2010  
202
T cells as therapeutic targets in SLE.
[20458333] Nat Rev Rheumatol 6(6): 317-25 (2010)
2011  
203
Clearing the complexity: immune complexes and their treatment in lupus nephritis.
[21694945] Int J Nephrol Renovasc Dis 4(-): 17-28 (2011)
2010  
204
Clinical outcome measures for cutaneous lupus erythematosus.
[20693208] Lupus 19(9): 1137-43 (2010)
2004  
205
Rationale for interleukin-6 blockade in systemic lupus erythematosus.
[15230289] Lupus 13(5): 339-43 (2004)
2010  
206
Understanding the epidemiology and progression of systemic lupus erythematosus.
[19136143] Semin Arthritis Rheum 39(4): 257-68 (2010)
2010  
207
Dendritic cells in systemic lupus erythematosus.
[20367140] Int Rev Immunol 29(2): 184-209 (2010)
2008  
208
Interferon alpha-induced lupus: proof of principle.
[18525429] J Clin Rheumatol 14(3): 131-2 (2008)
2008  
209
Neuropsychiatric systemic lupus erythematosus reconsidered.
[18200006] Nat Clin Pract Rheumatol 4(3): 112-3 (2008)
2008  
210
Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.
[18521755] Neuropsychol Rev 18(2): 149-66 (2008)
2010  
211
Neurologic manifestations of systemic lupus erythematosus in children and adults.
[19932376] Neurol Clin 28(1): 61-73 (2010)
2010  
212
Advances in lupus stemming from the parent-into-F1 model.
[20362509] Trends Immunol 31(6): 236-45 (2010)
2005  
213
SLE: translating lessons from model systems to human disease.
[16153890] Trends Immunol 26(11): 572-9 (2005)
2011  
214
Cause of systemic lupus erythematosus: a novel self-organized criticality theory of autoimmunity.
[22014010] Expert Rev Clin Immunol 7(6): 715-7 (2011)
2010  
215
Recent advances in the genetics of systemic lupus erythematosus.
[20441431] Expert Rev Clin Immunol 6(3): 461-79 (2010)
2010  
216
Anticytokine therapies in systemic lupus erythematosus.
[20636010] Immunotherapy 2(4): 575-82 (2010)
2009  
217
Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?
[18938110] Clin Immunol 130(2): 111-22 (2009)
2010  
218
Targeting B cells with biologics in systemic lupus erythematosus.
[20919800] Expert Opin Biol Ther 10(11): 1555-61 (2010)
2010  
219
Pathogenesis of human systemic lupus erythematosus: recent advances.
[20138006] Trends Mol Med 16(2): 47-57 (2010)
2009  
220
The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus.
[18992852] Autoimmun Rev 8(4): 320-4 (2009)
2010  
221
Pathways: Strategies for susceptibility genes in SLE.
[20144911] Autoimmun Rev 9(7): 473-6 (2010)
2009  
222
Overview of signal processing by the immune system in systemic lupus erythematosus.
[18722560] Autoimmun Rev 8(3): 177-8 (2009)
2009  
223
Aberrant T cell ERK pathway signaling and chromatin structure in lupus.
[18723128] Autoimmun Rev 8(3): 196-8 (2009)
2009  
224
Altered B cell receptor signaling in human systemic lupus erythematosus.
[18723129] Autoimmun Rev 8(3): 209-13 (2009)
2009  
225
Metabolic control of T cell activation and death in SLE.
[18722557] Autoimmun Rev 8(3): 184-9 (2009)
2009  
226
Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention.
[18722558] Autoimmun Rev 8(3): 204-8 (2009)
2008  
227
Novel molecular targets in the treatment of systemic lupus erythematosus.
[18190888] Autoimmun Rev 7(3): 256-61 (2008)
2008  
228
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.
[18817829] Hum Immunol 69(11): 790-6 (2008)
2008  
229
Inhibitory CD8+ T cells in autoimmune disease.
[18812196] Hum Immunol 69(11): 781-9 (2008)
2009  
230
The pathophysiology of hypertension in systemic lupus erythematosus.
[19158408] Am J Physiol Regul Integr Comp Physiol 296(4): R1258-67 (2009)
2011  
231
An update on belimumab for the treatment of lupus.
[21383914] Biologics 5(-): 33-43 (2011)
2010  
232
n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.
[20189790] Prostaglandins Leukot Essent Fatty Acids 82(4-6): 251-8 (2010)
2009  
233
Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations.
[19387456] Genes Immun 10(5): 470-7 (2009)
2009  
234
Fcgamma receptors: structure, function and role as genetic risk factors in SLE.
[19421223] Genes Immun 10(5): 380-9 (2009)
2003  
235
Alterations in leucocyte trafficking in lupus-prone mice: an examination of the MRL/faslpr mouse.
[12969327] Immunol Cell Biol 81(5): 390-6 (2003)
2008  
236
Interferon-inducible Ifi200-family genes in systemic lupus erythematosus.
[18598717] Immunol Lett 119(1-2): 32-41 (2008)
2010  
237
Key role of ERK pathway signaling in lupus.
[19961364] Autoimmunity 43(1): 17-22 (2010)
2010  
238
The biology of reactive intermediates in systemic lupus erythematosus.
[20001422] Autoimmunity 43(1): 56-63 (2010)
2010  
239
Regulation of autoreactive B cell responses to endogenous TLR ligands.
[20014959] Autoimmunity 43(1): 76-83 (2010)
2010  
240
Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.
[20014977] Autoimmunity 43(1): 84-97 (2010)
2007  
241
PTPN22: its role in SLE and autoimmunity.
[18075792] Autoimmunity 40(8): 582-90 (2007)
2008  
242
Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond.
[18432408] Autoimmunity 41(4): 278-86 (2008)
2009  
243
Why can't we find a new treatment for SLE?
[19329279] J Autoimmun 32(3-4): 223-30 (2009)
2010  
244
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.
[20724309] Ann Rheum Dis 69(12): 2074-82 (2010)
2011  
245
L2pB1: a new player in autoimmunity.
[21195478] Mol Immunol 48(11): 1292-300 (2011)
2010  
246
The management of peripheral blood cytopenias in systemic lupus erythematosus.
[20823093] Rheumatology (Oxford) 49(12): 2243-54 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia